Medicare Enrolled
Dr. David Morledge, M.D.
Neurology · Austin, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Morledge from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Morledge?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Morledge
Dr. David Morledge is a neurology specialist in Austin, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Morledge performed 32,594 Medicare services across 607 unique beneficiaries.
Between the years covered by Open Payments, Dr. Morledge received a total of $158,270 from 102 pharmaceutical and/or device companies across 1503 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Morledge is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in TX
$158,270 industry payments
Medicare Practice Summary
Medicare Utilization ↗32,594
Medicare services
Top 2% in TX for neurology
607
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,715 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
24,555 | $5 | $14 |
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
7,000 | $4 | $14 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
345 | $90 | $222 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $57 | $144 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
120 | $60 | $161 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
75 | $121 | $307 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 65 | $71 | $140 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
62 | $84 | $212 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
57 | $36 | $91 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
52 | $147 | $536 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $131 | $302 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
38 | $107 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $110 | $355 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $97 | $301 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
12 | $369 | $960 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$158,270
Total received (2018-2024)
Avg $22,610/year across 7 years
Top 4% in TX for neurology
102
Companies
1,503
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137,420 (86.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,614 (11.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,236 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$19,547
2023
$19,404
2022
$26,242
2021
$23,817
2020
$17,553
2019
$21,119
2018
$30,589
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$55,711
Biogen, Inc.
$22,701
Allergan, Inc.
$20,446
US WorldMeds, LLC
$15,389
AbbVie Inc.
$14,967
Allergan Inc.
$8,726
Genentech, Inc.
$2,020
Teva Pharmaceuticals USA, Inc.
$1,387
Novartis Pharmaceuticals Corporation
$1,228
Genentech USA, Inc.
$1,190
EMD Serono, Inc.
$890
Amgen Inc.
$729
Sunovion Pharmaceuticals Inc.
$687
ACADIA Pharmaceuticals Inc
$668
GENZYME CORPORATION
$666
UCB, Inc.
$548
Acorda Therapeutics, Inc
$540
Alexion Pharmaceuticals, Inc.
$502
Medtronic USA, Inc.
$481
Lilly USA, LLC
$464
MDD US Operations, LLC
$459
Supernus Pharmaceuticals, Inc.
$441
SK Life Science, Inc.
$386
Celgene Corporation
$328
Lundbeck LLC
$321
Abbott Laboratories
$318
Neurocrine Biosciences, Inc.
$298
Adamas Pharmaceuticals, Inc.
$287
Amneal Pharmaceuticals LLC
$274
PFIZER INC.
$274
Avanir Pharmaceuticals, Inc.
$239
Boston Scientific Corporation
$232
Akcea Therapeutics, Inc.
$231
GE HEALTHCARE
$224
Biohaven Pharmaceuticals, Inc.
$196
LivaNova USA, Inc.
$179
Merz North America, Inc.
$167
E.R. Squibb & Sons, L.L.C.
$166
Merz Pharmaceuticals, LLC
$149
Kyowa Kirin, Inc.
$144
Biohaven Pharmaceutical Holding Company Ltd.
$143
ARBOR PHARMACEUTICALS, INC.
$122
Upsher-Smith Laboratories LLC
$121
Corium, LLC
$121
Bausch Health US, LLC
$114
ARGENX US, INC.
$112
Takeda Pharmaceuticals U.S.A., Inc.
$108
Amylyx Pharmaceuticals, Inc.
$108
MITSUBISHI TANABE PHARMA AMERICA, INC.
$100
JAZZ PHARMACEUTICALS INC.
$95
Octapharma USA, Inc.
$95
Grifols USA, LLC
$91
Janssen Pharmaceuticals, Inc
$88
Eisai Inc.
$87
BOSTON SCIENTIFIC CORPORATION
$86
Sumitomo Pharma America, Inc.
$82
Assertio Therapeutics, Inc.
$72
AbbVie, Inc.
$62
Saol Therapeutics Inc.
$59
ANI Pharmaceuticals, Inc.
$59
UPSHER-SMITH LABORATORIES LLC
$56
AQUESTIVE THERAPEUTICS, INC.
$52
Arbor Pharmaceuticals, Inc.
$50
Bayer HealthCare Pharmaceuticals Inc.
$47
GE HealthCare
$44
SANOFI-AVENTIS U.S. LLC
$42
GRT US Holding, Inc.
$41
Vertical Pharmaceuticals, LLC
$39
Collegium Pharmaceutical, Inc.
$37
Mallinckrodt LLC
$36
CSL Behring
$36
Medtronic, Inc.
$34
Zyla Life Sciences, Inc.
$32
Promius Pharma LLC
$32
Egalet US Inc
$32
BioDelivery Sciences International, Inc.
$29
Strongbridge US INC.
$28
Kedrion Biopharma, Inc.
$25
InSightec,Inc
$24
Banner Life Sciences, LLC
$24
Zyla Life Sciences
$22
MERZ NORTH AMERICA, INC.
$21
Retrophin, Inc.
$20
TG Therapeutics, Inc.
$19
IMPEL PHARMACEUTICALS INC.
$19
EISAI INC.
$18
Amarin Pharma Inc.
$18
HOSPIRA, INC.
$17
Neurelis, Inc.
$17
Avion Pharmaceuticals
$17
CATALYST PHARMACEUTICALS, INC.
$16
OWP Pharmaceuticals, Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
Aprecia Pharmaceuticals, LLC
$15
Jazz Pharmaceuticals Inc.
$14
AstraZeneca Pharmaceuticals LP
$14
Shire North American Group Inc
$14
Scilex Pharmaceuticals Inc.
$13
Mylan Pharmaceuticals Inc.
$12
Neuronetics, Inc.
$12
Impax Laboratories, Inc.
$11
Purdue Pharma L.P.
$11
Top 3 companies account for 62.5% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Adlarity · Aduhelm · Aimovig · Albuked · Apokyn · Aptiom · Austedo XR · Azstarys · BAFIERTAM · BELBUCA · BIONIC NAVIGATOR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COPAXONE · Cambia · DUOPA · Deep Brain Stimulation · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · Evekeo · Exablate · FIRDAPSE · Fintepla · GAMMAGARD · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Glatiramer Acetate · Gocovri · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LIORESAL (BACLOFEN) · LYRICA · Leqembi · Lioresal (baclofen) · Lioresal Intrathecal (baclofen injection) · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PROCLAIM · PURIFIED CORTROPHIN GEL · Percept · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · RELEXXII · RELYVRIO · RYTARY · Radicava · Rebif · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · SYMPROIC · Soliris · Spritam · Subvenite · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vascepa · Vercise · Vimpat · Vyvanse · XARELTO · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZINBRYTA · ZIPSOR · ZOMIG · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in TX.
Equivalent to $486 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
126
Per 100K population
9.6
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Morledge is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with speaking/promotional industry engagement in the top 4% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Morledge experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Morledge performed 24,555 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Morledge receive payments from pharmaceutical companies?
Yes. Dr. Morledge received a total of $158,270 from 102 companies across 1,503 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Morledge's costs compare to other neurologists in Austin?
Dr. Morledge's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Morledge) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Austin
Browse neurologists in Austin ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology